- Home
- ATER vs NERV Comparison
ATER vs NERV Comparison
Compare ATER & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- NERV
- Stock Information
- Founded
- ATER 2014
- NERV 2007
- Country
- ATER United States
- NERV United States
- Employees
- ATER N/A
- NERV N/A
- Industry
- ATER Home Furnishings
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- ATER Consumer Discretionary
- NERV Health Care
- Exchange
- ATER Nasdaq
- NERV Nasdaq
- Market Cap
- ATER 22.8M
- NERV 18.3M
- IPO Year
- ATER N/A
- NERV 2014
- Fundamental
- Price
- ATER $2.18
- NERV $2.19
- Analyst Decision
- ATER Strong Buy
- NERV Hold
- Analyst Count
- ATER 1
- NERV 1
- Target Price
- ATER N/A
- NERV $5.00
- AVG Volume (30 Days)
- ATER 71.8K
- NERV 14.3K
- Earning Date
- ATER 11-11-2024
- NERV 11-05-2024
- Dividend Yield
- ATER N/A
- NERV N/A
- EPS Growth
- ATER N/A
- NERV N/A
- EPS
- ATER N/A
- NERV N/A
- Revenue
- ATER $107,193,000.00
- NERV N/A
- Revenue This Year
- ATER N/A
- NERV N/A
- Revenue Next Year
- ATER $5.47
- NERV N/A
- P/E Ratio
- ATER N/A
- NERV N/A
- Revenue Growth
- ATER N/A
- NERV N/A
- 52 Week Low
- ATER $0.23
- NERV $2.06
- 52 Week High
- ATER $3.95
- NERV $13.49
- Technical
- Relative Strength Index (RSI)
- ATER 27.26
- NERV 45.26
- Support Level
- ATER $2.33
- NERV $2.08
- Resistance Level
- ATER $2.60
- NERV $2.32
- Average True Range (ATR)
- ATER 0.16
- NERV 0.13
- MACD
- ATER -0.03
- NERV 0.01
- Stochastic Oscillator
- ATER 0.00
- NERV 33.33
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.